IL1R1 and rheumatoid arthritis: Post-infectious neurocognitive sequelae modeled in murine models show benefit from administration of anakinra, a USFDA approved medication that targets the IL-1R for the treatment of rheumatoid arthritis, during acute encephalitis (93).